Plex Dataset Name,Run Metadata ID,Number of Fractions,tmt_126,tmt_127n,tmt_127c,tmt_128n,tmt_128c,tmt_129n,tmt_129c,tmt_130n,tmt_130c,tmt_131
"PTRC_4patient_Plex_01_G","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-2","12","16-01225
Blood Derived Cancer - Peripheral Blood","16-01225
Blood Derived Cancer - Peripheral Blood","15-00701
Blood Derived Cancer - Peripheral Blood, Post-treatment","15-00701
Blood Derived Cancer - Peripheral Blood, Post-treatment","15-00276
Blood Derived Cancer - Peripheral Blood","15-00276
Blood Derived Cancer - Peripheral Blood","16-00886
Blood Derived Cancer - Peripheral Blood, Post-treatment","16-00886
Blood Derived Cancer - Peripheral Blood, Post-treatment","Universal Ref
Not Reported","Universal Ref
Not Reported"
"PTRC_4patient_Plex_02_G","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-1","12","16-00886
Blood Derived Cancer - Peripheral Blood, Post-treatment","16-00886
Blood Derived Cancer - Peripheral Blood, Post-treatment","15-00276
Blood Derived Cancer - Peripheral Blood","15-00276
Blood Derived Cancer - Peripheral Blood","15-00701
Blood Derived Cancer - Peripheral Blood, Post-treatment","15-00701
Blood Derived Cancer - Peripheral Blood, Post-treatment","16-01225
Blood Derived Cancer - Peripheral Blood","16-01225
Blood Derived Cancer - Peripheral Blood","Universal Ref
Not Reported","Universal Ref
Not Reported"
